Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Background Statins are the cornerstone treatment for patients with heterozygous familial hypercholesterolaemia but research suggests it could increase the risk of type 2 diabetes in the general population. A low prevalence of type 2 diabetes was reported in some familial hypercholesterolaemia cohort...
الحاوية / القاعدة: | LANCET DIABETES & ENDOCRINOLOGY |
---|---|
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
التنسيق: | مقال |
اللغة: | English |
منشور في: |
ELSEVIER SCIENCE INC
2024
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001381420900001 |